Efficacy and safety of laquinimod versus placebo in relapsing-remitting multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials.

This suggests that although laquinimod was associated with a numerical increase in the risk of arthralgia, it did not reach statistical significance, indicating that any difference in arthralgia occurrence might be attributable to chance rather than representing a true effect of the drug.

also in 111,027 other papers